2Han AR,Lee HR,Park BB, et al. Lymphoma-associated hemophagocytic syndrome:clinical features and treatment outcome. Ann Hematol, 2007 ; 86 : 493 - 498.
3Henter JI, Home A, Arico M, et al. HLH-2004: Diagnostic and Therapeutic Guidelines for Hemophagocytic Lymphohistioeytosis. Pediatr Blood Cancer, 2007 ; 48 : 124 - 131.
4Bielekova B, Catalfamo M, Reichert-Scrivner S, et al. Regulatory CD56(bright) natural killer cells mediate immunomodulatory effects of IL-2Ralpha-targeted therapy ( daclizumab ) in multiple sclerosis. Proc Natl Acad Sci USA, 2006; 103:5941 -5946.
5Kontopoulou T, Tsaousis G, Vaidakis E, et al. Hemophagocytic syndrome in association with visceral leishmaniasis. Am J Med, 2002; 113 : 439 - 440.
6Gupta A, Tyrrell P, Valani R, et al. The role of the initial bone marrow aspirate in the diagnosis of hemophagocytic lymphobistiocytosis. Pediatr Blood Cancer, 2008; 51:402-404.
7Henter JI, Home A, Arico M, et al. HLH-2004 : Diagnostic and therapeutic guidelines for hemophagocytic tymphohistiocytosis [ J ]. Pediatr Blood Cancer, 2007, 48(2) : 124-131.
8Grom AA. Natural killer cell dysfunction: a common pathway in systemic-onset juvenile rheumatoid arthritis, macrophage activation syndrome, and hemophagocytic lymphohistiocytosis [ J ] ? Arthritis Rheum, 2004, 50(3): 689-698.
9Okamoto M, Yamagnchi H. Analysis of triglyceride value in the diagnosis and treatment response of secondary hemophagocytie syndrome[J]. Intern Med, 2009, 48(10) : 775-781.
10Dhote R, Simon J, Papo T, et al. Reactive hemophagocytic syndrome in adult systemic disease : report of twenty-six cases and literature review[ J]. Arthritis Rheum, 2003, 49(5) : 633-639.
